Dichloroacetate: Clinical Trials

15 trials of Dichloroacetate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 2 terminated, 2 unknown, 1 no longer available. 5 Phase 1, 3 Not applicable, 2 Early Phase 1, 2 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 15Completed 4, Terminated 1
Not applicable3Completed 2, Terminated 1
Early Phase 12Completed 1, Recruiting 1
Phase 22Completed 1, Unknown 1
Phase 41Unknown 1

Follow Dichloroacetate: new trials by email Literature Review of Dichloroacetate trials Research Report on Dichloroacetate

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Regulation of Brain Glucose Metabolism in Type 1 Diabetes
Dichloroacetate - Diabetes Mellitus, Type 1, Hypoglycemia Unawareness
Early Phase 1RecruitingYale University162025-05-132026-06-09
A Clinical Trial to Evaluate Dichloroacetate (DCA) as a Treatment for Endometriosis-associated Pain
Dichloroacetate - Endometriosis
Not applicableCompletedUniversity of Edinburgh302019-11-192024-06-13
Development of Agents to Diminish the Risk of Hypoglycemia-induced Brain Injury in Type 1 Diabetes
Dichloroacetate, Placebo oral capsule - Hyperglycaemia (Diabetic)
Early Phase 1CompletedYale University212017-11-302021-01-22
13C-Pyruvate Breath Test
13C-Pyruvate 13C-lactate and dichloroacetate - Healthy
Phase 1CompletedUniversity of Florida52013-03-012015-12-02
Role of Preoperative Carbohydrates Drinks, Dichloroacetate and Exercise on Postoperative Muscle Insulin Resistance
Dichloroacetate, Carbohydrate drinks, Moderate intensity exercise - Insulin Resistance
Phase 4UnknownUniversity of Nottingham402012-05-012017-01-05
Pharmacotoxicology of Trichloroethylene Metabolites
Dichloroacetate, Genotyping, Leucine - Healthy
Not applicableTerminatedUniversity of Florida22011-08-012015-06-03
Study of DCA (Dichloroacetate) in Combination With Cisplatin and Definitive Radiation in Head and Neck Carcinoma
DCA (dichloroacetate), Placebo - Squamous Cell Carcinoma of the Head and Neck
Phase 2CompletedSanford Health502011-05-012020-10-27
Imaging and Biomarkers of Hypoxia in Solid Tumors
PET Scan, EF5, Carbogen - Neoplasms
Phase 1TerminatedStanford University282010-12-012017-11-06
Metabolic Reprogramming Therapy for Treatment of Recurrent Head and Neck Cancers
Dichloroacetate, EF5 - Head and Neck Cancer, Head and Neck Cancers
Phase 1CompletedDaniel T. Chang172010-08-012022-06-16
Study of the Safety and Efficacy of Dichloroacetate (DCA) in Glioblastoma and Other Recurrent Brain Tumors
Dichloroacetate - Brain Tumor, Glioblastoma
Phase 1CompletedUniversity of Florida152010-04-012015-09-22
A Phase I, Open-Labeled, Single-Arm, Dose Escalation, Clinical and Pharmacology Study of Dichloroacetate (DCA) in Patients With Recurrent and/or Metastatic Solid Tumours
Dichloroacetate - Neoplasms
Phase 1CompletedAHS Cancer Control Alberta232007-12-012016-03-11
Prevention of Dichloroacetate Toxicity
Nitisinone (NTBC), Dichloroacetate, Low-tyrosin diet - Acidosis, Lactic, Chronic Disease
Not applicableCompletedUniversity of Florida302001-09-012015-03-25
Evaluating the Effectiveness of a Dichloroacetate in MELAS Syndrome
Dichloroacetate - MELAS Syndrome
Phase 2UnknownEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)352000-03-012005-06-24
Dichloroacetate Kinetics, Metabolism and Toxicology
Dichloroacetate - Lactic Acidosis
CompletedNational Institute of Environmental Health Sciences (NIEHS)1001994-12-012006-09-04
Dichloroacetate Treatment of Congenital Lactic Acidosis Phase B: Expanded Access
Dichloroacetate - Mitochondrial Enzyme Deficiencies
No longer availableUniversity of Florida2017-08-08

Conditions studied

Acidosis, Lactic (3)  ·  Neoplasms (2)  ·  Acidosis (1)  ·  Brain Neoplasms (1)  ·  Chronic Disease (1)  ·  Diabetes Mellitus, Type 1 (1)  ·  Endometriosis (1)  ·  Genetic Diseases, Inborn (1)  ·  Glioblastoma (1)  ·  Head and Neck Neoplasms (1)  ·  Hyperglycemia (1)  ·  Insulin Resistance (1)  ·  MELAS Syndrome (1)  ·  Mitochondrial Diseases (1)  ·  Rare Diseases (1)

Sponsors

University of Florida (5)  ·  Yale University (2)  ·  AHS Cancer Control Alberta (1)  ·  Daniel T. Chang (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  National Institute of Environmental Health Sciences (NIEHS) (1)  ·  Sanford Health (1)  ·  Stanford University (1)  ·  University of Edinburgh (1)  ·  University of Nottingham (1)

Countries

United States (12)  ·  United Kingdom (2)  ·  Canada (1)

Top investigators

Peter W. Stacpoole, PhD, MD (3)  ·  Raimund Herzog, MD (2)  ·  Andrew W Horne, Prof (1)  ·  Daniel T Chang (1)  ·  Darryl C De Vivo, MD (1)  ·  Dileep N Lobo, Professor (1)  ·  Erin M. Dunbar, MD (1)  ·  Evangelos Michelakis, M.D. (1)  ·  Peter Venner, M.D. (1)  ·  Peter W Stacpoole, PhD, MD (1)  ·  Steven F Powell, MD (1)

Results publications

PMID 24297161, PMID 33712086, PMID 35312941

NIH funding

R01ES014617 (1), UL1TR000064 (1)